Basiliximabapplicationonliverrecipients:ameta-analysisofrandomizedcontrolledtrials
摘要: BACKGROUND:Thebenefitsoftheapplicationofbasiliximabinductiontherapyinlivertransplantationarenotclear.Thepresentmeta-analysiswastoevaluatetheprosandconsofbasiliximabuseinlivertransplantation.DATASOURCES:WesearchedtheassociatedpublicationsinEnglishfromJuly1998toDecember2015inthefollowingdatabases:MEDLINE,PubMed,Ovid,EMBASE,WebofScienceandCochraneLibrary.RESULTS:Basiliximabsignificantlydecreasedtheincidenceofdenovodiabetesmellitusafterlivertransplantation(RR=0.56;95%CI:0.34-0.91;P=0.02).Subgroupanalysisshowedthatbasiliximabincombinationwithsteroids-freeimmunosuppressantsignificantlydecreasedtheincidenceofbiopsy-provenacuterejection(RR=0.62;95%CI:0.39-0.97;P=0.04)andnew-onsethypertension(RR=0.62;95%CI:0.42-0.93;P=0.02).CONCLUSIONS:Basiliximabmaybeeffectiveinreducingdenovodiabetesmellitus.Whatismore,basiliximabincombinationwithsteroids-freeimmunosuppressantshowsstatisticalbenefittoreducebiopsy-provenacuterejectionanddenovohypertension. ...
(共8頁(yè))
開通會(huì)員,享受整站包年服務(wù)